AQR Capital Management »

Maxcyte shares owned by AQR Capital Management

Quarter-by-quarter ownership of Maxcyte (MXCT) shares owned by AQR Capital Management from 13F filings

Historical chart of AQR Capital Management investment in Maxcyte

Tip: Access up to 7 years of quarterly data

All positions including Maxcyte held by AQR Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maxcyte by AQR Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $138k 29k 4.70
2023-09-30 $50k 16k 3.12

More positions owned by AQR Capital Management

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Cisco Systems (CSCO)
Adobe Systems Incorporated (ADBE)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Pulte (PHM)
Cigna Corp (CI)
Humana (HUM)
CVS Caremark Corporation (CVS)

View all positions for AQR Capital Management

Top funds holding Maxcyte

Cadian Capital Management
Vanguard Group
Vitruvian Partners
Millennium Management
Portolan Capital Management
Massachusetts Financial Services
Blue Water Life Science Advisors
River & Mercantile Asset Management
Arrowpoint Asset Management
Dimensional Fund Advisors
Willis Investment Counsel
Fred Alger Management
Roubaix Capital
Lazard Asset Management
Bank of New York Mellon

View all funds holding Maxcyte